Sponsors

HESTA

We're a specialist industry super fund with deep connections to health and community services and those who, like them, make our world better.

'Super with impact' is the positive outcome we create by supporting our members to face the future with confidence, being a gutsy advocate for a fair and healthy community, and delivering investment excellence with impact.

Together, we can work for real-world impact.

For more information visit Super with Impact. Issued by H.E.S.T. Australia Ltd ABN 66 006 818 695 AFSL 235249, the Trustee of HESTA ABN 64 971 749 321.

This information is of a general nature. It does not take into account your objectives, financial situation or specific needs so you should look at your own financial position and requirements before making a decision. You may wish to consult an adviser when doing this. HESTA products can be found at Target Market Determination.

Before making a decision about HESTA products you should read the relevant Product Disclosure Statement or call 1800 813 327 and consider any relevant risks (visit Understanding Risk).

ConMed

ConMed is a global medical technology company committed to offering our customers the power of choice and convenience through a comprehensive range of cost effective, high quality products and services that are recognised as technological leaders across the specialties they serve.

Caregivers worldwide within the Orthopaedic, Sports Medicine, General Surgery, Gynaecology, Gastroenterology and Pulmonology markets have come to value the CONMED name to represent a continued dedication to innovation and ever present focus on improving clinical outcomes for the patients under their care.

ConMed Australia was established in 1998 as a subsidiary of CONMED Corporation. CONMED AUSTRALIA employs over 70 full time staff nationwide with a National head office based in Frenchs Forest (northern Sydney) and highly qualified representation in each state dedicated to providing healthcare products and comprehensive services that deliver enhanced clinical outcomes to our valued customers and their patients.

CONMED's broad range of market leading products

Orthopaedic

• Hall® Power Equipment - Pneumatic, Electric and Battery Driven Specialty, Large and Small Bone Power Equipment
• Arthroscopic Tissue Resection and Fluid Management Systems
• Sports Medicine Solutions, including: Shutt® and Concept® Manual Instruments, Shoulder, Knee and Hip Preservation Systems

General Surgery

• Electrosurgical Technologies
• Smoke Evacuation Solutions
• Clinical Solutions for Endoscopy Suites

Advanced Visualisations

• CONMED TrueHD™ Camera Systems - 2DHD 3MOS and 3CCD Options and 3DHD Vision System
• HD Endoscope Range and ScopeCare Repair Facility - Medicap Digital Documentation Systems

and Operating Theatre Integration

We welcome you to explore our World of Solutions at ConMed.

Johnson & Johnson MedTech

Worldwide

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson.

We embrace science and medical research – bringing the latest ideas, products and services to advance the health and well-being of people around the world.

Our family of companies

Comprises of:

• The world's premier consumer health company;
• The world's largest and most diverse medical devices and diagnostics company;
• The world's fifth-largest biologics company; and
• The world's eighth-largest pharmaceuticals company.

Employees of the Johnson & Johnson Family of Companies work with partners in healthcare to touch the lives of over a billion people every day, around the world.

We have more than 275 operating companies in more than 60 countries employing approximately 128,700 people.

For the past five years, we've consistently invested over 11 percent of sales to support our R&D efforts. This equates to over US$8 billion enterprise-wide in 2013. Our investments in R&D are helping us continually deliver meaningful innovations for our customers. About 25 percent of our sales have come from products we have introduced in just the past five years.

Johnson & Johnson see our citizenship and sustainability as more than our social, environmental and economic performance. Rather, it is who we are and how we act. It is how we lead and participate in helping solve the world's major healthcare challenges, protecting the environment and conserving resources we are privileged to use. It is how we conduct ourselves and our business to contribute positively to society.

We have contributed nearly US$1 billion in funds and products to support 600 programs in 50 countries in 2013. A number of these are in Australia and neighbouring countries, and include Careflight, Barnardos, Operation Smile and Interplast. We also provide a broad base of strong support to the Salvation Army, St Vincent de Paul and Mary MacKillop East Timor Mission to make a positive difference in the community.

In Australia

Johnson & Johnson Pty Ltd became an Australian entity in 1931.

Today, around 2000 people are employed by the Johnson & Johnson Family of Companies in Australia and New Zealand, and revenue from continuing operations is AUD$1.5bn.

There are four health and medical care-focused operating companies in Australia: Johnson & Johnson Medical, Janssen, Johnson & Johnson Pacific and Tasmanian Alkaloids.

Consumer healthcare

Johnson & Johnson Pacific

Johnson & Johnson Pacific Pty Ltd (JJP) is the largest over-the-counter supplier to retail Pharmacy in Australia serving over 4500 community pharmacies and ranking in the top five Health & Beauty suppliers to Australian Grocery.

We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. With our broad reach, JJP touches millions of consumers' lives every day. In fact, a JJP product is present in 7-out-of-10 Australian households. Many of our brands, including CODRAL®, SUDAFED® LISTERINE® Mouthwash, BAND-AID® Brand Adhesive Bandages, REGAINE®, NEUTROGENA® and JOHNSON'S® baby toiletries are #1 in the categories in which they compete. These brands bring value to people's daily lives, while our innovations in areas such as smoking cessation and sun protection are helping to advance the prevention of disease in the Australian population.

Devices & diagnostics

Johnson & Johnson Medical Companies

Our Medical Devices and Diagnostics (MD&D) business employs approximately 600 people in Australia. The business produces a broad range of innovative products and solutions used primarily by health care professionals in the fields of general surgery, orthopaedics, neurological disease, bariatric surgery, infection prevention, diagnostics, cardiovascular disease, and aesthetics.

The Johnson & Johnson MD&D business has more than 30 major new products undergoing a regulatory submission in the next two years. These products will further improve patient outcomes and expand our market leadership while facilitating the development of new business models. MD&D innovation is intended to help customers improve clinical outcomes, increase patient satisfaction and contain costs.

Pharmaceuticals

Janssen-Cilag Pty

Janssen-Cilag Pty Ltd (Janssen) employs 340 people in Australia and New Zealand passionate about addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer); immunology (e.g. ulcerative colitis, Crohn's disease and psoriasis); neuroscience (e.g. schizophrenia); infectious disease (e.g. HIV/AIDS and Hepatitis C); and cardiovascular and metabolic diseases (e.g. diabetes).

We have a proud heritage in our founder Dr Paul Janssen who established the company with a strong grounding in science and innovative solutions. Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.

Tasmanian Alkaloids

Tasmanian Alkaloids Pty Ltd is an advanced agricultural production and R&D company located in Westbury, near Launceston. It extracts alkaloids used in the manufacture of opiate-based pain-control medicines from poppy straw. Around 99 percent of this product is exported, making Tasmanian Alkaloids the largest manufacturer of active pharmaceutical ingredients in Australia, supplying 45-50% of the world's demand for medicinal opiates.

Tasmanian Alkaloids contracts with approximately 530 Tasmanian farmers to grow the poppy crop, and 50 additional contractors also linked to the agricultural operations. Export earnings of about AUD$170 million flow through the company to the Tasmanian economy with a multiplier effect of five times.

For more information, visit us at JnJ MedTech.

Baxter

Every day, millions of patients, caregivers, and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care.

For 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

For more information visit Baxter.

Wilhelm Integrated Solutions

Wilhelm is an Australian-owned healthcare technology company dedicated to improving outcomes for patients, clinicians, and health providers.

We design and deliver smarter, safer hospital environments — from modular digital operating rooms and critical care units to providing radiation safety, digital health and infection prevention and control solutions.

Trusted by Australia's leading private and public hospitals, Wilhelm brings together world-class technology, local engineering, and proven project delivery to help health facilities build smarter.

Our commitment to innovation, collaboration and service excellence makes Wilhelm a partner of choice in shaping the future of Australian healthcare.

For more information, visit: Wilhelm Integrated Solutions

northwest

Northwest Healthcare Properties is the largest owner, manager and developer (for long term ownership) of healthcare real estate in Australia and New Zealand.

Northwest specialises in market-leading hospital, health, and life sciences properties and precincts. As a capital provider, partner and landlord to the health sector the team of over 55 staff across offices in Melbourne, Sydney, Gold Coast and Auckland is solely dedicated to the investment in and development of healthcare real estate assets in this region, having done so for the last 25 years.

Find out more at northwest.

Service FM

At ServiceFM, we believe where people work matters. That's why we get personal, to create better work environments. Since 1979 we have created strategic partnerships to innovate, manage and maintain spaces that are safe, efficient, and enjoyable for the people who use these environments to do business.

Centred on a promise of Quality, Value and Flexibility, ServiceFM is dedicated to service excellence. As a trusted partner in the public and private sectors across Australia, we place the needs of our partners at the centre of everything we do.

In the healthcare sector, where cost pressures on private hospitals are far outstripping revenue streams, we see the need for better strategic partnerships with third party suppliers who can really support operations, while you focus on providing critical healthcare for the community.

Why this matters? All staff, patients and visitors rely on your facilities to never have downtime.

Proper management of assets in healthcare can save lives and benefit the livelihood of everyone. We embrace forward planning with proven systems to be reliable and adaptable as needed. We deliver 24/7 to ensure operational activities can carry on undisrupted.

From hospitals and surgical centres to long-term and aged-care facilities, our workplace environment solutions focus on the wellbeing, safety and security of patients, families, residents, and staff.

Safety is our highest priority, Manual Handling has been identified as our greatest mechanism of injury, and because of this, we benchmark our Lost Time Injury Frequency Rate on the healthcare industry benchmark of 8.8 (Key Work Health and Safety Statistics Australia 2023). ServiceFM has consistently maintained an LTIFR of below 7 for over two years.

We provide the following services:

• Asset Management
• Commercial Cleaning
• Commercial Hospitality
• Electrical Safety & Compliance
• Infection Control
• Operational Services
• Security
• Workplace Management

ServiceFM takes pride in our extensive national workforce and subcontractor network. Our dedicated teams operate in diverse terrain, from metro to regional and rural areas, with offices in Sydney, Melbourne, Brisbane, Perth and Adelaide.

We expect our workers to reflect our Cultural Values of Safety, Innovation, Integrity, Respect & Trust and Agility, whilst meeting the needs of our clients.

For more information visit ServiceFM.

Forbo

Forbo Flooring Systems design and manufacture leading flooring solutions for both healthcare and commercial environments.

Forbo products provide fit for purpose and design inspired solutions that offer low lifecycle costs, durability and world leading environmental performance. Forbo have the experience and range to offer tailored solutions in all areas, from dementia wards to operating theatres, treatment rooms, CSSD, kitchens and wet areas through to waiting rooms and offices. Forbo production facilities have a long history in healthcare with floors installed across millions of square meters within Australia and across the world since the early 1900's. Whether it be resilient safety flooring, textiles or specialist electroconductive solutions in clean rooms and surgical.

Forbo constantly seek to improve environmental processes with all manufacturing facilities certified to ISO 14001. Raw materials and sustainable energy are used efficiently, waste is recycled wherever possible, and CO2 emissions are measured and kept to an absolute minimum. Creating better environments requires a strong focus on responsible raw material sourcing that combines customer preference for quality, with care for the natural world. Forbo carefully select suppliers who reflect our corporate, sustainability and social concerns. Forbo Flooring Systems are committed to creating a sustainable future by working to 'compliance plus' and a circular model with a commitment to go above and beyond government regulations and requirements.

Forbo Flooring Systems are part of the Forbo Group, a global leader in flooring, bonding and movement systems. The company has an international network of 44 sites with production and distribution, and sales organisations in 35 countries worldwide. Forbo is headquartered in Baar, Switzerland.

To find out more visit Forbo Flooring Systems.

Medtronic

Engineering the extraordinary. Medtronic drives groundbreaking healthcare technology solutions that inspire hope and new possibility in people all over the world.

Inspiring the extraordinary, Medtronic's mission has motivated its people to do the extraordinary for 60 years - and counting.

To find out more visit Medtronic.

Device Technologies

Since 1992, Device Technologies has been dedicated to improving patients' lives through leading-edge technology and services. Successfully supplying hospitals and healthcare professionals with the finest medical solutions for their patients, Device Technologies continues to grow, with over 200 trusted brands and over 1,000 highly skilled staff throughout Australia, New Zealand and Asia.

Behind every brand distributed by Device Technologies is the knowledge of delivering leading technology into the most capable hands. Device Technologies nurtures relationships with healthcare professionals and customers, guiding the innovation process from concept to delivery and providing ongoing support with specialty training teams and field service engineers.

Find out more at Device Technologies.

h-trak

Private hospitals are highly dependent on efficient and transparent processes to treat a high number of patients while maintaining highest clinical standards. h-trak provides a solution to simplify and automate the tasks for inventory, purchasing, billing and reporting.

h-trak does this by providing a patient-centric inventory management solution designed from the ground up for the unique requirements of surgical or interventional departments within acute private hospitals. It includes a surgical preference card management system and integrates with the hospital's purchasing, finance, patient administration and billing systems and processes to ensure automatic and accurate billing, purchasing and cost reporting management.

h-trak is a SaaS (Software as a Service) solution which is the most cost effective and efficient means of providing software, via standard internet browsers. It can scale up to the very large corporate hospital providers but is also suitable for smaller independent private hospitals.

h-trak is used in more than 70 hospitals across Australia, Germany, UK and New Zealand, 52 of those in Australia. The system was established in 2002 in Australia and has been delivering benefits to our customers for more than 20 years. Further information can be found on our h-trak.

You can also contact us via email at .